Nome |
# |
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles, file e14fb269-a046-3de1-e053-1705fe0ac030
|
254
|
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells, file e14fb26c-72d3-3de1-e053-1705fe0ac030
|
174
|
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C, file e14fb268-a8d1-3de1-e053-1705fe0ac030
|
140
|
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity, file e14fb268-a8d3-3de1-e053-1705fe0ac030
|
134
|
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3), file e14fb268-aefd-3de1-e053-1705fe0ac030
|
121
|
SERPINB3 delays glomerulonephritis and attenuates the lupus-like disease in lupus murine models by inducing a more tolerogenic immune phenotype, file e14fb26b-8408-3de1-e053-1705fe0ac030
|
111
|
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells, file e14fb26a-3ddf-3de1-e053-1705fe0ac030
|
106
|
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma, file e14fb26b-11c9-3de1-e053-1705fe0ac030
|
87
|
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells., file e14fb267-adbd-3de1-e053-1705fe0ac030
|
77
|
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis, file e14fb26c-31c6-3de1-e053-1705fe0ac030
|
65
|
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation, file e14fb26e-e9bc-3de1-e053-1705fe0ac030
|
60
|
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma, file e14fb26e-6e04-3de1-e053-1705fe0ac030
|
56
|
Serpinb3 is overexpressed in the liver in presence of iron overload, file e14fb26a-3979-3de1-e053-1705fe0ac030
|
44
|
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma, file e14fb26a-3977-3de1-e053-1705fe0ac030
|
42
|
SERPINB3, apoptosis and autoimmunity, file e14fb267-8c1d-3de1-e053-1705fe0ac030
|
41
|
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour?, file e14fb267-9c97-3de1-e053-1705fe0ac030
|
29
|
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis, file e14fb26c-d9b4-3de1-e053-1705fe0ac030
|
22
|
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells, file e14fb267-7466-3de1-e053-1705fe0ac030
|
15
|
Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma, file e14fb267-851b-3de1-e053-1705fe0ac030
|
15
|
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis, file e14fb26f-a89e-3de1-e053-1705fe0ac030
|
15
|
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I., file e14fb267-b911-3de1-e053-1705fe0ac030
|
13
|
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study., file e14fb267-adbb-3de1-e053-1705fe0ac030
|
12
|
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma, file e14fb26d-85af-3de1-e053-1705fe0ac030
|
12
|
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells, file e14fb270-00d2-3de1-e053-1705fe0ac030
|
12
|
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study, file e14fb268-aefe-3de1-e053-1705fe0ac030
|
11
|
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo, file d46e6807-4b79-446e-85e4-5534ee75130b
|
10
|
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats., file e14fb268-cc40-3de1-e053-1705fe0ac030
|
9
|
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis., file e14fb267-98ca-3de1-e053-1705fe0ac030
|
8
|
SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS, file e14fb269-a044-3de1-e053-1705fe0ac030
|
8
|
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease, file e14fb267-a07a-3de1-e053-1705fe0ac030
|
7
|
Hepatic progenitor cells express SerpinB3., file e14fb267-b912-3de1-e053-1705fe0ac030
|
7
|
Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients, file e14fb26a-91c6-3de1-e053-1705fe0ac030
|
7
|
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation, file e14fb26f-be42-3de1-e053-1705fe0ac030
|
7
|
Occult liver disease burden: Analysis from a large general practitioners’ database, file e14fb269-9f8b-3de1-e053-1705fe0ac030
|
6
|
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer, file e14fb26a-bf62-3de1-e053-1705fe0ac030
|
6
|
Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients, file e14fb26a-dee5-3de1-e053-1705fe0ac030
|
6
|
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma, file e14fb267-8a3e-3de1-e053-1705fe0ac030
|
5
|
Liver pro-oncogenic potential of SERPINB3., file e14fb267-adbc-3de1-e053-1705fe0ac030
|
5
|
Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- And long-term prediction of hepatocellular carcinoma among cirrhotic patients, file e14fb26f-bc92-3de1-e053-1705fe0ac030
|
5
|
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice, file 90f17102-6ea0-4062-9177-9ec1a544488d
|
4
|
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3, file a8f4609d-2ee7-4f3e-b488-3d15dd0e9348
|
4
|
SERPINB3 modulates TGF-beta expression in chronic liver disease., file e14fb267-7f81-3de1-e053-1705fe0ac030
|
4
|
Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma., file e14fb267-82f9-3de1-e053-1705fe0ac030
|
4
|
SERPINB3 is associated with longer survival in transgenic mice., file 517ced10-7dad-4c58-ac54-cd8c4cbdc799
|
3
|
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice., file e14fb267-8d77-3de1-e053-1705fe0ac030
|
3
|
SerpinB3 as hepatic marker of post-resective shear stress, file e37fae42-1578-43b8-b304-80c17146ac2e
|
3
|
SerpinB3 administration protects liver against ischemia-reperfusion injury, file 07ef0ead-d21c-462e-81b0-707e20d62e46
|
2
|
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma, file 92950b1e-4454-49a6-bfd0-b5bd09caa9e8
|
2
|
Electronic sanitary database: a new potential tool to identify occult chronic liver disease in general population, file 945f126e-45b3-41d4-80a3-234a9d249b2e
|
2
|
Role of SERPINB3 in hepatocellular carcinoma., file e14fb267-ab67-3de1-e053-1705fe0ac030
|
2
|
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis, file e14fb267-b881-3de1-e053-1705fe0ac030
|
2
|
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation, file 210bfc19-975b-4681-8f1e-27e39ac873bb
|
1
|
Benign mesothelial cells in lymph nodes and lymphatic spaces associated with ascites, file e14fb268-9ada-3de1-e053-1705fe0ac030
|
1
|
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma, file e4611d7a-3f3a-4ad7-8855-03fa2d4af087
|
1
|
Totale |
1.802 |